# A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children

> **NCT00626808** · — · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 321697 (actual)

## Conditions studied

- Asthma
- Wheezing
- Immunosuppression

## Interventions

- **DRUG:** No Intervention

## Key facts

- **NCT ID:** NCT00626808
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 321697 (ACTUAL)
- **Last updated:** 2014-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00626808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00626808, "A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00626808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*